Sotera Health Company (SHC)
After hours:
| Previous Close | 11.20 |
| Open | 11.10 |
| Bid | 11.23 x 200 |
| Ask | 11.28 x 300 |
| Day's Range | 11.03 - 11.47 |
| 52 Week Range | 10.71 - 19.40 |
| Volume | |
| Avg. Volume | 1,881,442 |
| Market Cap | 3.19B |
| Beta (5Y Monthly) | 2.11 |
| PE Ratio (TTM) | 62.61 |
| EPS (TTM) | 0.18 |
| Earnings Date | May 02, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 16.80 |
GlobeNewswireSotera Health Reports First-Quarter 2024 Results
Q1 2024 net revenues increased 12.5% to $248 million, compared to Q1 2023Q1 2024 net income of $6 million or $0.02 per diluted share, compared to net income of $3 million or $0.01 per diluted share in Q1 2023Q1 2024 Adjusted EBITDA(1) increased 13.7% to $112 million, compared to Q1 2023Q1 2024 Adjusted EPS(1) of $0.13 compared to Adjusted EPS of $0.13 in Q1 2023Company reaffirms 2024 outlook CLEVELAND, May 02, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nas
ZacksSotera Health Company (SHC) Reports Next Week: Wall Street Expects Earnings Growth
Sotera Health (SHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- GlobeNewswire
Sotera Health Announces First-Quarter 2024 Earnings Release Date
CLEVELAND, April 11, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the first-quarter ended March 31, 2024 before the market opens on Thursday, May 2, 2024. Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Company’s oper
